Naslov
Endoscopic or No-Touch Vein Harvesting for CABG: What is Best for the Patient?

Autori
Kopjar, Tomislav ; Ivankovic, Stjepan ; Lima, Melchior Luiz ; Pinheiro, Bruno Botelho ; Dashwood, Michael Richard

Izvornik
Brazilian Journal of Cardiovascular Surgery (0102-7638) 31 (2016), 6; 461-464

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, znanstveni

Ključne riječi
Endoscopic, No-Touch Vein Harvesting, CABG

Sažetak
The saphenous vein (SV) is the most commonly used conduit for coronary artery bypass surgery (CABG), with minimally invasive endoscopic vein harvesting (EVH) being used in the majority of CABG in the USA. While the benefits of EVH include reduced wound complications and improved cosmetic outcome, an inferior patency rate of EVH-SVs compared to those harvested by open vein harvesting (OVH) has been reported (Figure 1). Previous guidance in the United Kingdom advised that EVH szhould only be used with special arrangements. This decision was based on data from the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV trial, where EVH-SV grafts showed higher failure rates than OVH grafts and, at 3 years, a higher death rate, myocardial infarction or revascularization compared to OVH grafts. Originally, the PREVENT IV trial was designed as a randomized controlled trial to assess the effectiveness and safety of edifoligide on angiographic SV graft failure 12-18 months following CABG, as well as the effect of edifoligide on major adverse cardiac events throughout 5 years after CABG. Considering that the study by Lopes et al.

Izvorni jezik
Hrvatski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

POVEZANOST RADA